期刊
NEUROBIOLOGY OF AGING
卷 70, 期 -, 页码 86-91出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.neurobiolaging.2018.06.006
关键词
beta-amyloid; Entorhinal cortex; Neuroinflammation; p38 alpha MAPK inhibitor; Long-term potentiation; Novel object recognition
资金
- CNR Research Project on Aging
- [U01 AG043415]
Neuroinflammation is a fundamental mechanism in Alzheimer's disease (AD) progression. The stress-induced activation of the p38 alpha mitogen-activated protein kinase (MAPK) leads to increased production of proinflammatory cytokines and neurodegeneration. We investigated the effects of an isoform selective p38 alpha MAPK inhibitor, MW01-18-150SRM (MW150), administered at 2.5 mg/kg/d (i.p.; 14 days) on early entorhinal cortex (EC) alterations in an AD mouse model carrying human mutations of the amyloid precursor protein (mhAPP). We used electrophysiological analyses with long-term potentiation induction in EC-containing brain slices and EC-relevant associative memory tasks. We found that MW150 was capable of rescuing long-term potentiation in 2-month old mhAPP mice. Acute delivery of MW150 to brain slices was similarly effective in rescuing long-term potentiation, with a comparable efficacy to that of the widely used multikinase inhibitor SB203580. MW150-treated mhAPP mice demonstrated improved ability to discriminate novel associations between objects and their position/context. Our findings suggest that the selective inhibition of the stress-activated p38 alpha MAPK with MW150 can attenuate the EC dysfunctions associated with neuroinflammation in an early stage of AD progression. (C) 2018 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据